23 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
treatments. The ongoing investment in IP development and enforcement reflects the commitment to sustaining the leadership position and delivering
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
4:50pm
demonstrates Medicenna’s continuing commitment to establish its presence in Boston, the leading biotechnology ecosystem
TORONTO and HOUSTON, Aug. 28, 2023 … to support the Company’s growth. This appointment underscores the Company's commitment to expanding its operations in Boston and follows the recent
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
) the level of effort, time, responsibility, ability, experience and level of commitment of the executive officer, (ii) market comparatives for similarly … and duties as directors (including the contribution individual directors are expected to make and the commitment of time and resources that the Corporation
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
22 Aug 22
Current report (foreign)
11:39am
takes into account, among other things (i) the level of effort, time, responsibility, ability, experience and level of commitment of the executive … and the commitment of time and resources that the Corporation expects from its directors).
The orientation includes an overview of the Corporation’s history
20-F
EX-1.3
mbn85ntapp11
22 Jun 22
Annual report (foreign)
5:04pm
20-F
5x1hg r6mwyfhza0sy86
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.3
xwjhp mt9bi
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-4.2
xq6bgkg91dtkvmk
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-11.1
4h58kh1 6k
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.1
d6i4e33qh
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.1
x151xikjfu9p7p1b x86
14 Sep 21
Current report (foreign)
8:32am
6-K
EX-99.1
m3j yrx6c
1 Sep 21
Current report (foreign)
8:00am
40-F
EX-99.1
8evferxc 1xa
28 May 21
Annual report (Canada)
12:12pm
40-F
EX-99.3
356r24lh 8z
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.1
sre543icohohbbdb
4 Sep 20
Current report (foreign)
2:50pm
6-K
EX-99.7
nxym9ije8zes7x9vn87
5 Aug 20
Condensed Consolidated Interim Statements of Financial Position
12:29pm
S-8
EX-99.4
prg28oom77eejn172
31 Jul 20
Registration of securities for employees
8:43am
S-8
EX-99.3
5y2k3n imn1ykl3t
31 Jul 20
Registration of securities for employees
8:43am
S-8
EX-99.1
k47w8c41n4m1ppmio1
31 Jul 20
Registration of securities for employees
8:43am